Recently, the Cormio et al. nomogram has been developed to predict prostate cancer (PCa) and clinically significant PCa using benign prostatic obstruction parameters. The aim of the present study was to externally validate the nomogram in a multicentric cohort.

Cindolo, L., Bertolo, R., Minervini, A., Sessa, F., Muto, G., Bove, P., et al. (2020). External validation of Cormio nomogram for predicting all prostate cancers and clinically significant prostate cancers. WORLD JOURNAL OF UROLOGY [10.1007/s00345-019-03058-1].

External validation of Cormio nomogram for predicting all prostate cancers and clinically significant prostate cancers

Bove P.;
2020-01-01

Abstract

Recently, the Cormio et al. nomogram has been developed to predict prostate cancer (PCa) and clinically significant PCa using benign prostatic obstruction parameters. The aim of the present study was to externally validate the nomogram in a multicentric cohort.
2020
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/24 - UROLOGIA
English
Nomograms; Prostate biopsy; Prostatic hyperplasia; Prostatic neoplasms; Validation
Cindolo, L., Bertolo, R., Minervini, A., Sessa, F., Muto, G., Bove, P., et al. (2020). External validation of Cormio nomogram for predicting all prostate cancers and clinically significant prostate cancers. WORLD JOURNAL OF UROLOGY [10.1007/s00345-019-03058-1].
Cindolo, L; Bertolo, R; Minervini, A; Sessa, F; Muto, G; Bove, P; Vittori, M; Bozzini, G; Castellan, P; Mugavero, F; Falsaperla, M; Schips, L; Celia, ...espandi
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/236860
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 9
  • ???jsp.display-item.citation.isi??? ND
social impact